Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 54 of 95, showing 5 Applications out of 474 total, starting on record 266, ending on 270

# Protocol No Study Title Investigator(s) & Site(s)

266.

ECCT/19/06/01   EPI 003
    A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa.   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
1. Ahero clinical triasl unit (Kisumu county)
2. KEMI CDC (Siaya county)
 
View

267.

ECCT/19/05/03   SEARCH
    Supportive Care and Antibiotics for Severe Pneumonia among Hospitalised Children    
Principal Investigator(s)
1. Ambrose Agweyu
Site(s) in Kenya
1. Mama Lucy Kibaki Hospital (Nairobi City county)
2. Kiambu County Referral Hospital (Kiambu county)
3. Machakos County Referral Hospital (Machakos county)
4. Embu County Referral Hospital (Embu county)
5. Naivasha County Hospital (Nakuru county)
6. Bungoma County Referral Hospital (Bung\'oma county)
7. Busia County Referral Hospital (Busia county)
8. Kitale County Referral Hospital (Trans Nzoia county)
9. Kisumu East Hospital (Kisumu county)
10. Kakamega County Referral Hospital, Kenya (Kakamega county)
 
View

268.

ECCT/19/05/02   ETNA
    EVALUATION OF TECHNOLOGIES FOR NEONATES IN AFRICA   
Principal Investigator(s)
1. PROF WILLIAM MAINA MACHARIA
Site(s) in Kenya
1. AGA KHAN UNIVERSITY HOSPITAL (Nairobi City county)
2. PUMWANI MATERNITY HOSPITAL (Nairobi City county)
 
View

269.

ECCT/19/05/01   A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 clinical trial to evaluate the safety and immunogenicity of recombinant HIV envelope protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in healthy, HIV--1 uninfected adults
    A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 clinical trial to evaluate the safety and immunogenicity of recombinant HIV envelope protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in healthy, HIV--1 uninfected adults   
Principal Investigator(s)
1. Omu Anzala
Site(s) in Kenya
KAVI-ICR KNH SITE
 
View

270.

ECCT/19/04/05   PHOENIx MDR-TB
    A5300B/I2003B/PHOENIx "Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients"   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
View